東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Novel Approaches to Improving Opioid...

Duron, David Isaiah.

FindBook

Google Book

Amazon

博客來

Novel Approaches to Improving Opioid Analgesic Therapy.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Novel Approaches to Improving Opioid Analgesic Therapy./
作者:	Duron, David Isaiah.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
面頁冊數:	145 p.
附註:	Source: Dissertations Abstracts International, Volume: 81-12, Section: B.
Contained By:	Dissertations Abstracts International81-12B.
標題:	Pharmacology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27741640
ISBN:	9798645466015

Novel Approaches to Improving Opioid Analgesic Therapy.
Duron, David Isaiah.

Novel Approaches to Improving Opioid Analgesic Therapy. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 145 p.

Source: Dissertations Abstracts International, Volume: 81-12, Section: B.

Thesis (Ph.D.)--The University of Arizona, 2020.

This item must not be sold to any third party vendors.

Despite their extensive side effect profile and potential for abuse, clinically used opioids such as morphine are still the most effective analgesics for most chronic pain patients. A negative stigma has been cast over opioids due to the recent opioid epidemic, which has claimed hundreds of thousands of lives over the past few decades in the United States alone. Despite this, there is still great potential for the use of these drugs if negative side effect profiles, especially reward and addiction, can be reduced or eliminated. Here we identify a pharmacological and non-pharmacological means for enhancing analgesic potency while reducing side effect profiles attributed to systemic morphine. We have uncovered a novel regulator of downstream mu opioid receptor (MOR) signaling within the spinal cord, heat shock protein 90 (HSP90). Within the spinal cord, HSP90 prevents MOR induced ERK MAPK phosphorylation which otherwise activates RSK2 and subsequent translation, leading to enhanced morphine induced anti-nociception. By selectively inhibiting HSP90 within the spinal cord, morphine induced anti-nociception is elevated without impacting side effects, and therefore allows for a dose reduction strategy while achieving equi-efficacious anti-nociception. Additionally, we have uncovered a novel consequence of dietary intervention on opioid pharmacology. Through daily intermittent fasting (IF), morphine induced anti-nociception is enhanced and prolonged, while several side effects including reward, constipation, and tolerance are reduced. MOR functionality but not expression within various brain regions is altered due to daily IF which may account for the behavioral differences in systemic morphine treatments seen with IF. These two approaches attempt to alter opioid pharmacology not by modifications to new drugs, but by altering opioid physiology to maximize the desired effect of anti-nociception while reducing side effects. Together these novel approaches may allow for rapid translation into the clinic and lead to additional research efforts to improve existing opioids with the aim of treating chronic pain in patients while reducing side effects and abuse.

ISBN: 9798645466015Subjects--Topical Terms:

634543
Pharmacology.
Subjects--Index Terms:

Heat shock protein 90

Novel Approaches to Improving Opioid Analgesic Therapy.
LDR:03315nmm a2200373 4500 001 2269343
005 20200908090448.5
008 220629s2020 ||||||||||||||||| ||eng d
020 $a 9798645466015
035 $a (MiAaPQ)AAI27741640
035 $a AAI27741640
040 $a MiAaPQ $c MiAaPQ
100 1 $a Duron, David Isaiah. $3 3546663
245 1 0 $a Novel Approaches to Improving Opioid Analgesic Therapy.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 145 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-12, Section: B.
500 $a Advisor: Streicher, John M.
502 $a Thesis (Ph.D.)--The University of Arizona, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Despite their extensive side effect profile and potential for abuse, clinically used opioids such as morphine are still the most effective analgesics for most chronic pain patients. A negative stigma has been cast over opioids due to the recent opioid epidemic, which has claimed hundreds of thousands of lives over the past few decades in the United States alone. Despite this, there is still great potential for the use of these drugs if negative side effect profiles, especially reward and addiction, can be reduced or eliminated. Here we identify a pharmacological and non-pharmacological means for enhancing analgesic potency while reducing side effect profiles attributed to systemic morphine. We have uncovered a novel regulator of downstream mu opioid receptor (MOR) signaling within the spinal cord, heat shock protein 90 (HSP90). Within the spinal cord, HSP90 prevents MOR induced ERK MAPK phosphorylation which otherwise activates RSK2 and subsequent translation, leading to enhanced morphine induced anti-nociception. By selectively inhibiting HSP90 within the spinal cord, morphine induced anti-nociception is elevated without impacting side effects, and therefore allows for a dose reduction strategy while achieving equi-efficacious anti-nociception. Additionally, we have uncovered a novel consequence of dietary intervention on opioid pharmacology. Through daily intermittent fasting (IF), morphine induced anti-nociception is enhanced and prolonged, while several side effects including reward, constipation, and tolerance are reduced. MOR functionality but not expression within various brain regions is altered due to daily IF which may account for the behavioral differences in systemic morphine treatments seen with IF. These two approaches attempt to alter opioid pharmacology not by modifications to new drugs, but by altering opioid physiology to maximize the desired effect of anti-nociception while reducing side effects. Together these novel approaches may allow for rapid translation into the clinic and lead to additional research efforts to improve existing opioids with the aim of treating chronic pain in patients while reducing side effects and abuse.
590 $a School code: 0009.
650 4 $a Pharmacology. $3 634543
650 4 $a Alternative medicine. $3 536195
650 4 $a Neurosciences. $3 588700
653 $a Heat shock protein 90
653 $a Intermittent fasting
653 $a Opioids
653 $a Pain
653 $a Spinal cord
690 $a 0419
690 $a 0496
690 $a 0317
710 2 $a The University of Arizona. $b Medical Pharmacology. $3 1682535
773 0 $t Dissertations Abstracts International $g 81-12B.
790 $a 0009
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27741640